Rapid Micro Biosystems (NASDAQ:RPID) CFO Sells $67,635.68 in Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CFO Sean Wirtjes sold 17,254 shares of the stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $3.92, for a total value of $67,635.68. Following the transaction, the chief financial officer owned 563,674 shares in the company, valued at $2,209,602.08. The trade was a 2.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Rapid Micro Biosystems Stock Performance

NASDAQ:RPID opened at $3.89 on Monday. The company has a quick ratio of 2.95, a current ratio of 4.23 and a debt-to-equity ratio of 0.42. Rapid Micro Biosystems, Inc. has a twelve month low of $1.86 and a twelve month high of $4.94. The company has a fifty day moving average of $3.67 and a 200-day moving average of $3.41. The firm has a market capitalization of $172.40 million, a P/E ratio of -3.85 and a beta of 1.38.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on RPID shares. Wall Street Zen raised shares of Rapid Micro Biosystems from a “sell” rating to a “hold” rating in a research report on Saturday, February 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Rapid Micro Biosystems presently has an average rating of “Hold” and a consensus target price of $8.00.

Institutional Investors Weigh In On Rapid Micro Biosystems

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Millennium Management LLC bought a new position in Rapid Micro Biosystems in the 4th quarter valued at about $338,000. 683 Capital Management LLC bought a new position in shares of Rapid Micro Biosystems in the fourth quarter valued at approximately $350,000. OMERS ADMINISTRATION Corp bought a new position in shares of Rapid Micro Biosystems in the fourth quarter valued at approximately $71,000. Fifth Lane Capital LP purchased a new position in shares of Rapid Micro Biosystems during the fourth quarter valued at approximately $51,000. Finally, Barclays PLC bought a new stake in Rapid Micro Biosystems during the fourth quarter worth $72,000. 52.60% of the stock is owned by institutional investors.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.